Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

Moderna Stock Skyrockets on Reports of U.S. Cancer Vaccine Initiative

Moderna (MRNA) shares ripped higher on Friday as reports of a planned U.S. initiative to accelerate cancer vaccine development renewed enthusiasm for its oncology business. According to The New York Times, the proposed public-private partnership would bring together federal researchers, drugmakers, nonprofits and patients, with a launch expected in December.

Moderna stock has been nothing short of a blockbuster investment in 2026, currently trading at about 7x its price at the start of this year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.